{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:29:27Z","timestamp":1761870567820,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.3816\/clml.2011.n.009","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T15:21:13Z","timestamp":1352820073000},"page":"64-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["CD30-Positive EBV\u2013Associated Diffuse Large B-Cell Lymphoma Occurring After Immunosuppressive Therapy for T-Cell Prolymphocytic Leukemia"],"prefix":"10.3816","volume":"11","author":[{"given":"Ahmad","family":"Alduaij","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana O.","family":"Treaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Winer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLML.2011.n.009_bib1","series-title":"World Health Organization Classification of Tumors: Pathology and Genetics of tumors of Haematpoietic and Lymphoid Tissues","first-page":"270","article-title":"T-cell Prolymphocytic leukemia","author":"Catovsky","year":"2008"},{"key":"10.3816\/CLML.2011.n.009_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1385\/MO:23:1:17","article-title":"T-cell prolymphocytic leukemia","volume":"23","author":"Dearden","year":"2006","journal-title":"Med Oncol"},{"key":"10.3816\/CLML.2011.n.009_bib3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0165-4608(97)00410-X","article-title":"Abnormalities of chromosomes 8, 11, 14, and X in T-prolymphocytic leukemia studies by fluorescence in situ hybridization","volume":"103","author":"Maljaei","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.3816\/CLML.2011.n.009_bib4","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1182\/blood.V91.10.3920.3920_3920_3926","article-title":"Inactivation of the ATM Gene in T-Cell Prolymphocytic Leukemias","volume":"91","author":"Stoppa-Lyonnet","year":"1998","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.009_bib5","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-02-0593","article-title":"Blood concentrations of alemtuzumab and antiglobulin responses in patients with chronic lymphocytic leukemia following intravenous or subcutaneous routes of administration","volume":"104","author":"Hale","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.009_bib6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1182\/blood-2002-01-0159","article-title":"Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL)","volume":"100","author":"Lundin","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLML.2011.n.009_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1309\/72CM-KAXF-66DE-4XVA","article-title":"Peripheral T-cell lymphoma complicated by a proliferation of large B cells","volume":"114","author":"Higgins","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.3816\/CLML.2011.n.009_bib8","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2169\/internalmedicine.34.118","article-title":"Smoldering adult T-cell leukemia with B-cell lymphoma and early gastric cancer","volume":"34","author":"Kodama","year":"1995","journal-title":"Intern Med"},{"key":"10.3816\/CLML.2011.n.009_bib9","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12185-008-0176-2","article-title":"Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma","volume":"88","author":"Weisel","year":"2008","journal-title":"Int J Hematol"},{"key":"10.3816\/CLML.2011.n.009_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/BF02981943","article-title":"Concurrent Hodgkin's disease (mixed cellularity type) and T-cell chronic lymphocytic leukemia\/prolymphocytic leukemia","volume":"73","author":"Miyata","year":"2001","journal-title":"Int J Hematol"},{"key":"10.3816\/CLML.2011.n.009_bib11","first-page":"47","article-title":"T-cell prolymphocytic leukemia complicated by diffuse large B-cell lymphoma of the stomach","volume":"42","author":"Miyata","year":"2001","journal-title":"Rinsho Ketsueki"},{"key":"10.3816\/CLML.2011.n.009_bib12","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1200\/JCO.2009.24.4194","article-title":"Epstein-barr virus-positive diffuse large B-cell lymphoma during therapy with alemtuzumab for T-cell prolymphocytic leukemia","volume":"28","author":"Sohani","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLML.2011.n.009_bib13","first-page":"24570","article-title":"An EBV-positive lymphoproliferative disorder after therapy with alemtuzumab","volume":"349","author":"Ghobrial","year":"2003","journal-title":"N Engl J Med"},{"key":"10.3816\/CLML.2011.n.009_bib14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jcv.2008.07.018","article-title":"Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro","volume":"43","author":"Lan","year":"2008","journal-title":"J Clin Virol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011701306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265011701306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:24:38Z","timestamp":1761870278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265011701306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S2152265011701306"],"URL":"https:\/\/doi.org\/10.3816\/clml.2011.n.009","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD30-Positive EBV\u2013Associated Diffuse Large B-Cell Lymphoma Occurring After Immunosuppressive Therapy for T-Cell Prolymphocytic Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLML.2011.n.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}